Member Info for MALTBY2002

We know Myles and Paul Hill have agreed on questions to ask Al on Monday and clearly there is much of interest regarding royalty payments with the existing partnerships that we have been building up. Of equal interest would be Al discussing potential royalty payments from providing manufacturers around the world with our Covid affimer. If he does then that would be our first indication of potential revenues from this.

Paul Hill has already said at least part of the interview will be about third part royalties which given the present cash balance will be of interest given that it is presently a grey area.

So was the spike in the SP today the result of playing catch-up regarding the 2 RNS’s earlier in the week or a leek regarding potential news tomorrow re BAMS or the Ce?

This might explain the reason why Paul Hill will be discussing third party royalty opportunities early next week with Al with more details on this deal and others then. Something else to look forward to

Further vindication of the affimer with another licensing agreement

Interesting that Paul will be talking to Al amongst other things on Monday on the topic of third party royalty opportunities. We might get some background on the £48 million cash at the beginning of the year. Interesting topic to choose with a bit of BAMS news thrown in hopefully

Easily insert affimer reagents. We have the LFD structure in place now to detect all viruses now not just Covid

I would be prepared to sacrifice a bit of profit to ensure us Brits get a good quality test free and available to all without fleecing the taxpayer

The other issue is that been tied to HMG also guarantees manufacturing capacity that may not otherwise have been there

And guess which test meets the new priority criteria

Not got a link but the Telegraph have an exclusive on PD working on a new rapid LFD that will unlock summer sport. Could be us !!

https://pbs.twimg.com/card_img/1364982956884971523/ION-MaLN?format=jpg&name=small

Why would Avacta want to take the Mologic ISO accreditation now when it will have its own by the end of March? The obvious explanation is that it wants to supply the market with tests before the end of March. Schools anyone?

Waiting for Boris. Game on!

We won’t need to wait for Boris in the House of Commons all is likely to be revealed in one of the papers tomorrow most likely the ST. Different tests for different markets both within the UK and beyond, throw in BAMS and we could well corner a fair proportion of the global market. We are indeed in a better position than last night as it looks as though we have one test through, AN, to be announced Monday and the saliva test shortly to be approved. RNS for me nailed on at some stage on Monday with the TU later in the week to clarify some of the issues raised today

The timing of the after hours publication of the article and the status of the author both indicate a deliberate leak by Whitehall in the knowledge that it would be picked up by the wider media. The only surprise was that there was no leak prior to publication. Leaking key information in this way is the modus operandi of this Government. A 7am RNS inevitable unless the SP is suspended prior to Bojo’s statement. The issue for us is how many manufacturers globally have been lined up as we should not become obsessed by the UK market. What part will Medusa play? Congratulations to all LTH and particularly Al and his team who have received unwarranted stick for circumstances not of their making.

The point about trust is a very good one as this has been undermined by the quality of the first generation tests. Bojo needs to address this issue and if he can wrap it around the UK leading the world in diagnostic testing as well as vaccinations he will do.Great news for cancer sufferers today and reinforces the view to people observing AVCT for the first time we are very much not a one trick pony. The other point is the UK is a mere 1% of the global market and we also have BAMS

Listened to a number of media outlets today and without exception it has included people questioning the validity of the present LFT and their concerns about the impact of false negatives. Clearly few if any people are joining the dots up from our initial test results announced yesterday. In order to stop further erosion of The credibility of the the LFD before roll out there has to be a Government backed PR campaign explaining the improvements to accuracy of the new second generation tests. Step forward AVCT

Who knows may drop in to BBI solutions??

Whilst the SP moves inevitably towards and beyond £2 a quick thank you to Myles, Ophidian, BBN and others who no longer comment on here but whose research in the past have helped people like myself to build a substantial holding in this company